Pfm Health Sciences, LP Werewolf Therapeutics, Inc. Transaction History
Pfm Health Sciences, LP
- $1.71 Billion
- Q3 2024
A detailed history of Pfm Health Sciences, LP transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 3,398,747 shares of HOWL stock, worth $5.4 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
3,398,747
Previous 3,241,074
4.86%
Holding current value
$5.4 Million
Previous $7.91 Million
8.89%
% of portfolio
0.42%
Previous 0.41%
Shares
12 transactions
Others Institutions Holding HOWL
# of Institutions
69Shares Held
31.8MCall Options Held
700Put Options Held
500-
Ra Capital Management, L.P. Boston, MA6.14MShares$9.77 Million0.18% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$6.81 Million6.25% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$3.8 Million0.79% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$3.42 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2MShares$3.18 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $47M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...